MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
EYPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

EyePoint (EYPT) Ownership - Who owns EyePoint?

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 833 393-7646
Employees
214
Web
https://www.eyepoint.bio

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
987.65M
P/E Ratio
N/A
Total Cash
222.55M
Projected Growth
N/A
Total Debt
20.23M
Revenue
7.61M
Risk (Beta)
2.72
Dividend Yield
N/A
Total Cash/Share
2.65
Total Debt/Equity
N/A
Revenue/Share
0.10 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
EYPT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for EYPT
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 833 393-7646
Employees
214
Web
https://www.eyepoint.bio